Lead Product(s) : Dellera
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dante Genomics Creates Separate Drug Discovery And Development Company Genomic Biopharma Inc.
Details : A computational approach to design a COVID-19 vaccine against a predicted SARS-CoV-2 variant: high immunogenicity, efficacy and safety of DELLERA vaccine.
Product Name : Dellera
Product Type : Vaccine
Upfront Cash : Inapplicable
October 26, 2022
Lead Product(s) : Dellera
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Merck & Co
Deal Size : Undisclosed
Deal Type : Collaboration
IRBM to Collaborate with MSD to Develop Peptides Against Coronavirus
Details : IRBM will leverage previous research into SARS to contribute to identifying and developing a potential treatment of SARS-CoV-2, as well as other future life-threatening coronavirus strains.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 21, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Merck & Co
Deal Size : Undisclosed
Deal Type : Collaboration